International Vaccinology Course and Fellowship 2025

Overview

The International Vaccine Institute (IVI) invites applications for its 24th International Vaccinology Course, titled “Vaccines in a Changing World: Innovation and Access.” The course will take place from 8-12 September 2025 in three locations: Seoul, Republic of Korea, Kigali, Rwanda, and Stockholm, Sweden.

Course

IVI’s International Vaccinology Course is a training program to build knowledge and practical skills in vaccine science and development. Through lectures, quizzes, case studies, networking opportunities, and site visits to tour vaccine manufacturing facilities, the course trains vaccine professionals through an inclusive and immersive experience. World-renowned experts from various fields in vaccinology, immunology, epidemiology, communication, and related fields serve as faculty members.

Established in 2000, the International Vaccinology Course is one of the longest-running vaccinology courses in Asia and is a vital component of IVI’s work to accelerate the development of safe, effective, and affordable vaccines for global health. The program has trained nearly 5,000 vaccine professionals from across the world in person and certified an additional 1,100 participants through an online course, fostering lasting collaborative partnerships in research and public health.

IVI 24th International Vaccinology Course in 2025

The 24th International Vaccinology Course will take place 8-12 September 2025 in three locations: Seoul, Republic of Korea; Kigali, Rwanda; and Stockholm, Sweden. Details, including registration, course curriculum, and sessions, will be announced later. Check this page for updates.

2025 IVI Vaccinology Fellowship

The 2025 IVI Vaccinology Fellowship grants all-inclusive financial support to selected researchers early in their careers from low- and middle-income countries (LMICs) who demonstrate potential leadership in public health in their home countries and current workplaces, enabling them to attend the 24^th International Vaccinology Course in Seoul or Kigali.

The fellowship covers the course fee, airfare to/from Incheon International Airport (Seoul) or Kigali, accommodation for the duration of the course, meals, visa fees, travel insurance, and ground transportation. Selected fellows are expected to present a poster during the poster session of the course.

We particularly welcome fellowship applications from researchers early in their career. Applicants from Africa are strongly encouraged to apply to the Kigali location, while applicants from the Americas, Europe, Asia, and Australia/Oceania are strongly encouraged to apply to the Seoul location. The Stockholm, Sweden location will not be participating in the fellowship program.

The deadline to submit IVI Vaccinology Fellowship applications is 26 May 2025 at 23:59 Korea Standard Time. All completed applications must be submitted through the links below. View an example of an application form here (Seoul) and here (Kigali).

Apply for a 2025 IVI Vaccinology Fellowship in Seoul

Applicants from low- and middle-income countries in the Americas, Europe, Asia, and Australia/Oceania are strongly recommended to attend the course at the Seoul, Republic of Korea, location. Selected fellows will attend the course in Seoul at IVI’s headquarters.

Apply for a fellowship in Seoul

Apply for a 2025 IVI Vaccinology Fellowship in Kigali

Applicants from low- and middle-income countries in Africa are strongly encouraged to apply to attend the course at the Kigali, Rwanda location. Selected fellows will attend the course at our partner site co-hosted by the University of Rwanda in Kigali.

Apply for a fellowship in Kigali

Key dates

The International Vaccinology Course is open to participants from around the world working, studying, or conducting research within topics relevant to vaccinology and biotechnology. The course will be offered at all three sites in Seoul, Kigali, and Stockholm for non-fellow participants. General registration will open on 12 May 2025, and information about fees and other details will be available on this page.

Official announcement